Skip to content

Investigating caffeine consumption in psychiatric inpatients

Investigating caffeine consumption in psychiatric inpatients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00040071
Enrollment
400
Registered
2026-05-11
Start date
2026-05-07
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychiatric inpatients, irrespective of diagnosis.

Interventions

Group 1: Participation in the study takes place once during the inpatient stay on a psychiatric ward. Interested patients will be personally informed about the study by a member of the research team.

Sponsors

LVR-Universitätsklinik Essen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inpatient stay at LVR Clinic Essen and capacity to provide informed consent.

Exclusion criteria

Exclusion criteria: Severe cognitive impairment, dementia, acute crisis states, acute intoxication.

Design outcomes

Primary

MeasureTime frame
Primary outcome measures of the study are the daily caffeine intake (in mg), the participants’ primary psychiatric diagnosis, and their subjective sleep quality.

Secondary

MeasureTime frame
Secondary variables include basic sociodemographic data (e.g., age, sex).

Countries

Germany

Contacts

Public ContactNorbert Scherbaum

LVR-Universitätsklinik Essen

norbert.scherbaum@uni-due.de+49 201 7227-200

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026